Literature DB >> 24315965

Eastern promises: Additive role of metabolic syndrome for thromboembolic risk stratification in Taiwanese atrial fibrillation patients.

Sanjay Dixit1, Vinay Kini2.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24315965      PMCID： PMC6007979          DOI： 10.1016/j.hrthm.2013.12.001

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN： 1547-5271            Impact factor:   6.343


× No keyword cloud information.
  10 in total

1.  Risk factors and incidence of ischemic stroke in Taiwanese with nonvalvular atrial fibrillation-- a nation wide database analysis.

Authors:  Lian-Yu Lin; Chang-Hsing Lee; Chih-Chieh Yu; Chia-Ti Tsai; Ling-Pin Lai; Juey-Jen Hwang; Pau-Chung Chen; Jiunn-Lee Lin
Journal:  Atherosclerosis       Date:  2011-04-05       Impact factor: 5.162

2.  Added predictive ability of the CHA2DS2VASc risk score for stroke and death in patients with atrial fibrillation: the prospective Danish Diet, Cancer, and Health cohort study.

Authors:  Torben Bjerregaard Larsen; Gregory Y H Lip; Flemming Skjøth; Karen Margrete Due; Kim Overvad; Lars Hvilsted Rasmussen
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-04-24

3.  Clinical outcome in Japanese elderly patients with non-valvular atrial fibrillation taking warfarin: a single-center observational study.

Authors:  Miyoko Naganuma; Tsuyoshi Shiga; Kumi Sato; Kagari Murasaki; Masayuki Hashiguchi; Mayumi Mochizuki; Nobuhisa Hagiwara
Journal:  Thromb Res       Date:  2011-12-03       Impact factor: 3.944

4.  Additive effect of the metabolic syndrome score to the conventional CHADS₂ score for the thromboembolic risk stratification of patients with atrial fibrillation.

Authors:  Chia-Ti Tsai; Shu-Hsuan Chang; Sheng-Nan Chang; Juey-Jen Hwang; Cho-Kai Wu; Yi-Chih Wang; Chuen-Den Tseng; Huei-Ming Yeh; Ling-Ping Lai; Fu-Tien Chiang; Jiunn-Lee Lin
Journal:  Heart Rhythm       Date:  2013-11-16       Impact factor: 6.343

5.  The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy.

Authors:  Michiel Coppens; John W Eikelboom; Robert G Hart; Salim Yusuf; Gregory Y H Lip; Paul Dorian; Olga Shestakovska; Stuart J Connolly
Journal:  Eur Heart J       Date:  2012-09-27       Impact factor: 29.983

6.  Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort.

Authors:  Gregory Y H Lip; Lars Frison; Jonathan L Halperin; Deirdre A Lane
Journal:  Stroke       Date:  2010-10-21       Impact factor: 7.914

7.  Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

Authors:  Gregory Y H Lip; Robby Nieuwlaat; Ron Pisters; Deirdre A Lane; Harry J G M Crijns
Journal:  Chest       Date:  2009-09-17       Impact factor: 9.410

8.  Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin.

Authors:  Brian F Gage; Carl van Walraven; Lesly Pearce; Robert G Hart; Peter J Koudstaal; B S P Boode; Palle Petersen
Journal:  Circulation       Date:  2004-10-11       Impact factor: 29.690

9.  Gender differences in smoking behaviors in an Asian population.

Authors:  Yi-Wen Tsai; Tzu-I Tsai; Chung-Lin Yang; Ken N Kuo
Journal:  J Womens Health (Larchmt)       Date:  2008 Jul-Aug       Impact factor: 2.681

Review 10.  Prevention of stroke in patients with nonvalvular atrial fibrillation.

Authors:  R G Hart; D G Sherman; J D Easton; J A Cairns
Journal:  Neurology       Date:  1998-09       Impact factor: 9.910
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.